Advertisement

European Journal of Clinical Pharmacology

, Volume 75, Issue 3, pp 303–311 | Cite as

Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children

  • Philippe VorilhonEmail author
  • Bastien Arpajou
  • Hélène Vaillant Roussel
  • Étienne Merlin
  • Bruno Pereira
  • Aurélie Cabaillot
Review

Abstract

Purpose

Upper respiratory tract infection (URTI) is a common infection in children, generally caused by viral respiratory infection. Vitamin C is currently proposed as prophylaxis for URTI. The purpose of this study was to assess the effectiveness of vitamin C administration in children for the prevention and reduced duration of URTI through a systematic literature review.

Methods

Review of the literature conducted between October 2017 and January 2018 in the main medical databases (CENTRAL, Medline and Embase) and by a gray literature approach. The selection criteria were: double-blind randomized controlled trials (RCTs) comparing vitamin C use to placebo in children aged 3 months to 18 years without chronic infection. Efficacy was assessed in terms of incidence, duration and severity of symptoms of URTI. A meta-analysis was conducted where possible.

Results

Eight RCTs, including 3135 children aged 3 months to 18 years, were selected. Quantitative analysis showed no difference between vitamin C administration and placebo (odds ratio = 0.75, 95% CI [0.54–1.03], p = 0.07, I2 = 74%). Vitamin C administration was found to decrease the duration of URTI by 1.6 days (standardized mean differences = −0.30 [−0.53; −0.08], p = 0.009, I2 = 70%). Children under 6 years of age benefit from more effective vitamin C supplementation associated with echinacea. No serious adverse events were reported.

Conclusions

Although no preventive effects were found, vitamin C intake reduced the duration of URTI. Considering the frequency of URTI, the inappropriate prescription of antibiotics, and the safe nature of vitamin C, its supplementation is justified, especially in children under 6 years of age and those who present a high frequency of URTI. There is a sound rationale for further trials with greater statistical power among children of this age.

Keywords

Upper respiratory tract infection Vitamin C Infants Adolescents Systematic review 

Abbreviations

URTI

Upper respiratory tract infection

CG

Control group

CI

Confidence interval

IG

Intervention group

RCT

Randomized controlled trial

RR

Relative risk

SMD

Standardized mean difference

Notes

Acknowledgements

The authors thank Mrs. Nathalie Pinol-Domenech, documentarian at Clermont Auvergne University Campus Health Library. We also thank Mr. Constantini for providing clarifications and additional data for this study.

Authors’ contributions

BA, AC and PV conceptualized and designed the study, selected studies and planned the analysis. BA, PV, BP and AC contributed to the development of the selection criteria, the assessment strategy for the risk of bias and the data extraction criteria; BP provided statistical expertise. AC, BA and PV drafted the manuscript and HVR and EM participated in its improvement. All authors read, provided feedback and approved the final manuscript as submitted.

Supplementary material

228_2018_2601_MOESM1_ESM.docx (1.7 mb)
ESM 1 (DOCX 1704 kb)

References

  1. 1.
    Monto AS (2002) Epidemiology of viral respiratory infections. Am J Med 112(Suppl 6A):4S–12SCrossRefGoogle Scholar
  2. 2.
    Parkin PC, Taylor CY, Petric M et al (2002) Controlled study of respiratory viruses and wheezing. Arch Dis Child 87:221–222CrossRefGoogle Scholar
  3. 3.
    InVS | BEH n°01 (6 janvier 2009) Observatoire Hivern@le – KhiObs : surveillance épidémiologique des pathologies hivernales de la sphère ORL chez l’enfant en France. Les recours pour asthme dans les services des urgences d’Île-de-France, 2006–2007. Epidémiologie de la cryptosporidiose humaine en France en 2006 et 2007 : données du réseau Cryptosporidies Anofel. http://invs.santepubliquefrance.fr/beh/2009/01/index.htm. Accessed 3 Jan 2018
  4. 4.
    Manzella JP, Roberts NJ (1979) Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. J Immunol 123:1940–1944Google Scholar
  5. 5.
    Anderson TW (1977) Large scale studies with vitamin C. Acta Vitaminol Enzymol 31:43–50Google Scholar
  6. 6.
    Anderson TW, Suranyi G, Beaton GH (1974) The effect on winter illness of large doses of vitamin C. Can Med Assoc J 111:31–36Google Scholar
  7. 7.
    Anderson TW, Beaton GH, Corey P, Spero L (1975) Winter illness and vitamin C: the effect of relatively low doses. Can Med Assoc J 112:823–826Google Scholar
  8. 8.
    Dykes MH, Meier P (1975) Ascorbic acid and the common cold. Evaluation of its efficacy and toxicity. JAMA 231:1073–1079CrossRefGoogle Scholar
  9. 9.
    Chalmers TC (1975) Effects of ascorbic acid on the common cold. An evaluation of the evidence. Am J Med 58:532–536CrossRefGoogle Scholar
  10. 10.
    Karlowski TR, Chalmers TC, Frenkel LD et al (1975) Ascorbic acid for the common cold. A prophylactic and therapeutic trial. JAMA 231:1038–1042CrossRefGoogle Scholar
  11. 11.
    Hemilä H, Chalker E (2013) Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev:CD000980.  https://doi.org/10.1002/14651858.CD000980.pub4
  12. 12.
    Shamseer L, Moher D, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647CrossRefGoogle Scholar
  13. 13.
    Cochrane handbook for systematic reviews of interventions | Cochrane Training. http://training.cochrane.org/handbook. Accessed 18 Jan 2018
  14. 14.
    Murad MH, Montori VM, Ioannidis JPA et al (2014) How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA 312:171–179.  https://doi.org/10.1001/jama.2014.5559 CrossRefGoogle Scholar
  15. 15.
    Wilson CW, Loh HS, Foster FG (1973) Common cold symptomatology and vitamin C. Eur J Clin Pharmacol 6:196–202CrossRefGoogle Scholar
  16. 16.
    Garaiova I, Muchová J, Nagyová Z et al (2015) Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study. Eur J Clin Nutr 69:373–379.  https://doi.org/10.1038/ejcn.2014.174 CrossRefGoogle Scholar
  17. 17.
    Constantini NW, Dubnov-Raz G, Eyal B-B et al (2011) The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial. Eur J Pediatr 170:59–63.  https://doi.org/10.1007/s00431-010-1270-z CrossRefGoogle Scholar
  18. 18.
    Cohen HA, Varsano I, Kahan E et al (2004) Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med 158:217–221.  https://doi.org/10.1001/archpedi.158.3.217 CrossRefGoogle Scholar
  19. 19.
    Bancalari A, Seguel C, Neira F et al (1984) Prophylactic value of vitamin C in acute respiratory tract infections in schoolchildren. Rev Med Chil 112:871–876Google Scholar
  20. 20.
    Ludvigsson J, Hansson LO, Tibbling G (1977) Vitamin C as a preventive medicine against common colds in children. Scand J Infect Dis 9:91–98CrossRefGoogle Scholar
  21. 21.
    Coulehan JL, Reisinger KS, Rogers KD, Bradley DW (1974) Vitamin C prophylaxis in a boarding school. N Engl J Med 290:6–10.  https://doi.org/10.1056/NEJM197401032900102 CrossRefGoogle Scholar
  22. 22.
    Coulehan JL, Eberhard S, Kapner L et al (1976) Vitamin C and acute illness in Navajo school children. N Engl J Med 295:973–977.  https://doi.org/10.1056/NEJM197610282951802 CrossRefGoogle Scholar
  23. 23.
    Miller JZ, Nance WE, Kang K (1978) A co-twin control study of the effects of vitamin C. Prog Clin Biol Res 24(Pt C):151–156Google Scholar
  24. 24.
    Miller JZ, Nance WE, Norton JA et al (1977) Therapeutic effect of vitamin C. A co-twin control study. JAMA 237:248–251CrossRefGoogle Scholar
  25. 25.
    Ritzel G (1961) Critical evaluation of vitamin C as a prophylactic and therapeutic agent in colds. Helv Med Acta 28:63–68Google Scholar
  26. 26.
    Karsch-Völk M, Barrett B, Kiefer D et al (2014) Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev:CD000530.  https://doi.org/10.1002/14651858.CD000530.pub3
  27. 27.
    Hao Q, Dong BR, Wu T (2015) Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev:CD006895.  https://doi.org/10.1002/14651858.CD006895.pub3
  28. 28.
    Quick M (2015) Cochrane commentary: probiotics for prevention of acute upper respiratory infection. Explore N Y N 11:418–420.  https://doi.org/10.1016/j.explore.2015.07.012 CrossRefGoogle Scholar
  29. 29.
    Kenealy T, Arroll B (2013) Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 6:CD000247.  https://doi.org/10.1002/14651858.CD000247.pub3 Google Scholar
  30. 30.
    Grüber C, Keil T, Kulig M et al (2008) History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol 19:505–512.  https://doi.org/10.1111/j.1399-3038.2007.00688.x CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of General PracticeClermont Auvergne University, Faculty of MedicineClermont-FerrandFrance
  2. 2.Clermont Auvergne University, CNRS, SIGMA Clermont, Institut PascalClermont-FerrandFrance
  3. 3.Department of General Medicine, Faculty of Medicine of Clermont-FerrandUniversité d’AuvergneClermont-FerrandFrance
  4. 4.Clinical Investigation Center, INSERM-CIC 1401, Clermont-Ferrand University HospitalClermont-FerrandFrance
  5. 5.UPU ACCePPT, Clermont Auvergne UniversityClermont-FerrandFrance
  6. 6.Pediatrics, Clermont-Ferrand University HospitalClermont-FerrandFrance
  7. 7.Pediatrics, INSERM-CIC 1405, Clermont-Ferrand University HospitalClermont-Ferrand Cedex 1France
  8. 8.Biostatistics Unit (Clinical Research and Innovation Department)Clermont-Ferrand University HospitalClermont-FerrandFrance
  9. 9.Clermont Auvergne University, Inserm 1107, Neuro-Dol, Observatoire Français des Médicaments Antalgiques (OFMA)Clermont-FerrandFrance

Personalised recommendations